𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New drugs for aggressive B-cell and T-cell lymphomas

✍ Scribed by Niels Murawski; Michael Pfreundschuh

Book ID
117785464
Publisher
The Lancet
Year
2010
Tongue
English
Weight
116 KB
Volume
11
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

AGGRESSIVE NON-HODGKIN'S LYMPHOMA: T-CEL
AGGRESSIVE NON-HODGKIN'S LYMPHOMA: T-CELL VERSUS B-CELL
✍ RAYMOND LIANG; DAVID TODD; FAITH C. S. HO πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 364 KB πŸ‘ 2 views

This study aimed to define the clinical characteristics, treatment outcome and independent prognostic factors of 144 patients with T-and 357 B-cell non-Hodgkin's lymphomas. Entities with well-defined immunophenotype and clinical characteristics were excluded. Patients with T-cell tumours were younge

Comparison of peripheral T-cell lymphoma
Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma
✍ Naoto Tomita; Shigeki Motomura; Rie Hyo; Hirotaka Takasaki; Sachiya Takemura; Ju πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Peripheral T‐cell lymphomas (PTCLs) are a biologically heterogeneous subgroup of lymphomas with poor prognosis. In this study, the authors analyzed the clinical behaviors of PTCLs and diffuse large B‐cell lymphoma (DLBCL). ## METHODS The authors compared the characteris